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Abstract The early response gene IEX-1 modulates apoptosis
and cell growth in a poorly defined fashion. Here, we describe the
effect of hammerhead ribozymes specifically disrupting IEX-1
expression in 293 cells. Compared to vector control, 293 cells
exhibit a reduced growth rate and a slowed cell cycle progression,
when stably transfected with a concatemeric ribozyme construct.
In addition, these 293 cells were much less sensitive to apoptosis
induced by an activating Fas/CD95 antibody or by the anti-
cancer drugs etoposide and doxorubicin. By modulating the cell
cycle, IEX-1 might be part of a growth signal if favourable
growth conditions prevail, whereas under unfavourable condi-
tions, i.e. death receptor activation, IEX-1 facilitates apo-
ptosis. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Induced expression of the early response gene
p22PRG1=IEXÿ1 has been demonstrated in association with pro-
liferation, adaptation and stress response of various cell types
[1^3]. This is related to the actions of growth factors, like
human, plasmid-derived and epidermal growth factors [1,4],
of cytokines, like interleukin 1L or tumour necrosis factor K
[2,4^6], to the in£uence of cellular stress, like radiation [2,7],
or to viral infection [8]. The IEX-1 promoter contains several
functional binding sites for transcription factors like AP-1,
nuclear factor (NF)-UB and p53 [9,10], thus underscoring
the putative role of IEX-1 as a gene contributing to growth
control and apoptosis. A recently described splicing variant,
designated IEX-1L, has been reported to account for NF-UB-
dependent inhibition of apoptosis [11], but it has been shown
that IEX-1L is merely a transdominant negative mutant of
IEX-1 that does not exist in vivo [12]. Other studies demon-
strated growth-promoting activity of IEX-1 in certain cell
lines [7], but growth-inhibiting activity in others [13].
To elucidate in what fashion and to what extent IEX-1
contributes to the regulation of cell growth and survival, we
made use of the hammerhead ribozyme technique for func-
tional disruption of IEX-1. This technique o¡ers great poten-
tial to cleave an individual mRNA with high speci¢city and
e⁄cacy. Using 293 cells, we investigated the e¡ect of abol-
ished IEX-1 expression on cell cycle progression, growth
rate and apoptotic sensitivity. It could be shown that ribo-
zyme-mediated disruption of IEX-1 expression reduces growth
rate and cell cycle progression as well as the apoptotic sensi-
tivity of 293 cells.
2. Materials and methods
2.1. Chemicals
3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sul-
fophenyl)-2H-tetrazolium salt (MTS) proliferation assay CellTiter 96
was from Promega, Mannheim, Germany; Dulbecco’s modi¢ed essen-
tial medium (DMEM), glutamine and foetal calf serum (FCS) were
from Biochrom, Berlin, Germany; puromycin, doxorubicin and eto-
poside were from Sigma, Deisenhofen, Germany; CH-11 anti-Fas
antibody was from Coulter Immunotech, Hamburg, Germany; re-
striction endonucleases were from Life-Technology, Karlsruhe, Ger-
many.
2.2. Cell culture
293 cells (Invitrogen; Schelp, The Netherlands) were cultured in
DMEM (10% FCS, 1% glutamine) at 37‡C, 85% humidity and a
5% CO2 atmosphere.
2.3. In vitro transcription of ribozymes, generation of concatemeric
vector-based ribozymes
Synthetic DNA oligonucleotides (Biometra-Whatman, Go«ttingen,
Germany) were used as template for T7-primed in vitro transcription
using the AmpliScribe T7 High-Yield transcription kit (Epicentre).
Ribozymal RNA was separated by urea^PAGE and puri¢ed as de-
scribed recently [14]. Vector-based concatemeric ribozyme constructs
were generated by single or consecutive ligation of annealed DNA
templates via terminal 5P-NheI and 3P-XbaI restriction sites into the
pCDNA2.1 vector (Invitrogen). Via XbaI and PmeI restriction sites,
the IEX-1 intron £anked by a 5P-XbaI and a 3P-PmeI site was ligated
directly adjacent to the ribozyme insert. In this way, an antisense
monomer targeted to position 290, or concatemers targeted to posi-
tions 114, 287, 290 and 293 of the IEX-1 mRNA (GenBank accession
number S81914) were generated. Via £anking BamHI and SalI restric-
tion sites, the entire inserts were subcloned into the retroviral expres-
sion vector pBabePuro [15].
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2.4. Transient and stable transfection of ribozyme constructs
Transient transfection was carried out as described [12]. For stable
transfection, the pBabePuro ribozyme vectors were subjected to in
vitro packaging in 293T cells as described elsewhere [16]. The virus
supernatants were used for transduction of 293 cells, selected for
3 weeks with 1 Wg/ml puromycin.
2.5. Reverse transcription and PCR
Total RNA was isolated using the RNeasy kit (Qiagen), treated
with DNase I and reverse transcribed into single-stranded cDNA as
described [12]. Genomic DNA was isolated using the Blood and Cell
culture DNA Kit (Qiagen). The integration of ribozymal cDNA into
the genome was veri¢ed by PCR (95‡C, 5 min/95‡C, 30 s; 63‡C, 30 s;
72‡C, 30 s; for 25 cycles/72‡C, 10 min; GeneAmp PCR System 2400,
Perkin-Elmer) using 1.5 U Taq polymerase (Life Technologies) and
the provirus-speci¢c primers 5P-cggatcccaagctggctagcag-3P (forward)
and 5P-acagtcgacgctgatcagcggg-3P (reverse). For RT-PCR, 2 Wl
cDNA was subjected to PCR (95‡C, 2 min/95‡C, 60 s; 58‡C, 30 s;
72‡C, 30 s; for 25 cycles/72‡C, 10 min) using 1.5 U Taq polymerase
(Life Technologies) and forward/reverse primers speci¢c for virus-in-
tegrated ribozyme 9 (5P-gcagaactgatgagtccttg-3P/5P-caccatcgtttcgtccc-
gaa-3P), ribozyme 2/8/9 (5P-aggtgaactgatgagtcctt-3P/5P-caccatcgtttc-
gtcccgaa-3P) and ribozyme 2/8/9/10 (5P-aggtgaactgatgagtcctt-3P/5P-
atcgtcttttcgtcccgaag-3P). All PCR products were separated by PAGE
(8% polyacrylamide) and visualised by ethidium bromide staining.
2.6. Northern and Western blotting
IEX-1 Western blotting was performed as described recently [12].
As control, a monoclonal antibody against K-tubulin (Sigma) was
used. Northern blots were performed following the procedure essen-
tially described by Sambrook et al. [17] using a PCR-generated IEX-1
probe (position 610^845), 32P-labelled by random priming.
2.7. Measurement of apoptosis
Apoptosis was measured by means of the annexin V binding assay
(ApoAlert, Clontech). Brie£y, 105 cells were pelleted, resuspended in
200 Wl of HEPES-bu¡ered saline, and 10 Wl of FITC-labelled en-
hanced annexin V and 100 ng of propidium iodide (PI) were added.
Upon incubation for 15 min at room temperature in the dark, samples
were brought to 0.5 ml with phosphate-bu¡ered saline. Analysis was
done by £uorescence £ow cytometry (Galaxy Argon Plus, Dako), and
the results were analysed with the FLOMAX software (Dako). Those
cells exhibiting high staining with annexin V were regarded as being
apoptotic.
2.8. Cell cycle analysis
Cells were prepared and stained with PI as described recently [12],
and analysed by £uorescence £ow cytometry. Cell cycle analysis was
carried out using the FLOMAX software (Dako).
2.9. Proliferation assay
For the determination of cellular growth rate, stably transfected 293
cells (5000 per well) were seeded onto 96-well plates and cultured for
24 h. Upon overnight serum starvation, cells were cultured in the
absence or presence of FCS for 30 h. Then, 25 Wl of the MTS reagent
(Promega) was added to each well (200 Wl medium) and further in-
cubated. After periods of 30, 60, 120 and 240 min, plates were ana-
lysed on an ELISA reader at 490 nm.
3. Results
Using synthetic DNA oligonucleotides as template that are
composed of the ribozymal backbone sequence, the catalytic
region and the bipartite substrate binding region, 12 hammer-
head ribozyme RNAs were generated by means of T7-primed
in vitro transcription (Table 1). These antisense ribozymes
were targeted to various potential cleavage sites (GUC/A) of
IEX-1 mRNA since the trinucleotide GUC/A should be an
e⁄cient target [18] and were used for cleavage of in vitro
transcribed substrate RNA consisting of exon 1 or exon 2
of IEX-1. As shown by PAGE and subsequent ethidium bro-
mide staining, 11 of the 12 ribozymes speci¢cally cleaved the
RNA templates at the expected positions (Fig. 1A), whereas
no cleavage occurred on any of the other exon-derived IEX-1
RNAs (data not shown). As demonstrated for one of these
ribozymes, cleavage was rapid and time-dependent, producing
an increasing signal of the cleavage product, whilst the
amount of intact RNA decreased (Fig. 1B).
Ribozymes were further tested on an in vitro transcribed
RNA substrate consisting of the entire coding region of IEX-1
and a small part of the 3P-untranslated region. As shown in
Fig. 1C, the RNA substrate was again cleaved by eight di¡er-
ent ribozymes, yielding fragments of the expected sizes. In
another experiment, the e⁄cacy of the ribozymes was tested
on total RNA isolated from 293 cells. As shown by Northern
blot analysis, signi¢cant amounts of the 1.3-kb IEX-1 mRNA
were detectable (Fig. 1D). Compared to untreated RNA, ri-
bozyme treatment reduced the amount of IEX-1 mRNA,
whereas 18S or 28S rRNAs remained una¡ected (not shown).
Obviously, ribozymes 8 and 9, which cleave IEX-1 mRNA at
adjacent positions, were most e⁄cient since they not only
reduced the amount of the 1.3-kb RNA molecule, but also
produced signi¢cant amounts of a smaller cleavage product.
In order to provide a ribozyme construct with higher tran-
scription e⁄cacy and enhanced cleavage activity, ribozymes 2,
8 and 9 or 2, 8, 9 and 10 were fused to each other, 3P-end-
Table 1
Nucleotide sequences of the DNA templates for anti-IEX-1 hammerhead ribozymes
Ribozyme number/cleavage position Sequence
Exon 1:
Ri1/36 accatgtgtttcgtcccgaaggactcatcagactctcgcctatagtgagtcgtatta
Ri2/134* tcctgagatttcgtcccgaaggactcatcagttcacctcctatagtgagtcgtatta
Ri3/143 cttcaccttttcgtcccgaaggactcatcaggaccctccctatagtgagtcgtatta
Ri4/40 tgtgtcactttcgtcccgaaggactcatcagtcgcagccctatagtgagtcgtatta
Ri5/150 ttcgaccctttcgtcccgaaggactcatcagtcccggacctatagtgagtcgtatta
Ri6/193 ccagcgcctttcgtcccgaaggactcatcagtcgcgggcctatagtgagtcgtatta
Exon 2:
Ri7/49 aaaaggcttttcgtcccgaaggactcatcagtctttctcctatagtgagtcgtatta
Ri8/69* gctcaccatttcgtcccgaaggactcatcaggtcttctcctatagtgagtcgtatta
Ri9/72* caccatcgtttcgtcccgaaggactcatcagttctgcccctatagtgagtcgtatta
Ri10/75* catcgtcttttcgtcccgaaggactcatcagtgccagacctatagtgagtcgtatta
Ri11/197 atctgacttttcgtcccgaaggactcatcagggagccccctatagtgagtcgtatta
Ri12/258 ggccgccttttcgtcccgaaggactcatcagtaactggcctatagtgagtcgtatta
Twelve oligonucleotides were used as templates for in vitro transcription of hammerhead ribozymes targeted to various positions of exons 1
and 2 of IEX-1. Nucleotides in bold indicate IEX-1-speci¢c regions. *The corresponding positions of Ri2, 8, 9 and 10 in the IEX-1 mRNA
(GenBank accession number S81914) are 114, 287, 290 and 293, respectively.
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linked to the IEX-1 intron and cloned into a retroviral ex-
pression vector (pBabePuro), as well as ribozyme 9 alone.
Upon selection with puromycin for 3 weeks, stably transfected
293 cells were tested for the integration of the expression
construct into the genome. As shown in Fig. 2A, PCR on
genomic DNA detected the ribozyme templates in ribozyme-
transfected, but not in mock-transfected cells. The expression
of concatemeric ribozymal RNAs in ribozyme-transfected
cells was analysed by RT-PCR. As shown in Fig. 2B, speci¢c
PCR products were produced from DNase-treated total RNA
prior to reverse transcription. In mock-transfected cells, no
PCR product could be detected. Northern and Western blot-
ting revealed signi¢cantly reduced levels of the 1.3-kb IEX-1
mRNA and the 22-kDa IEX-1 protein, respectively, in ribo-
zyme-expressing 293 cells (Fig. 2C,D) that were otherwise
abundantly present in serum-treated 293 cells transfected
with the empty vector. Compared to the single ribozyme
Ri9, the concatemeric ribozymes Ri2/8/9 and Ri2/8/9/10
were slightly more and much more e⁄cient, respectively.
To test the e¡ect of ribozyme expression on the cell cycle,
293 cells were treated with serum (5% FCS). As shown by cell
cycle analysis (Fig. 3), mock-transfected 293 cells did not ex-
hibit an alteration in the cell cycle pro¢le compared to un-
transfected cells. In contrast, the concatemeric ribozymes Ri2/
8/9/10 and Ri2/8/9 and to a lesser extent Ri9 caused a shift in
the cell cycle pro¢le: the fraction of 293 cells residing in the
G1 phase increased slightly from 60^64% of mock- or un-
transfected cells to 67^70% if the anti-IEX-1 ribozymes were
expressed. Concomitantly, the fraction of G2/M cells was re-
duced from 20% to 10^14% if 293 cells expressed the ribo-
zymes 9, 2/8/9 or 2/8/9/10. Under these conditions, the number
of cells residing in the S phase (19^21%) did not change sig-
ni¢cantly.
In order to elucidate whether disruption of IEX-1 expres-
sion a¡ects cell growth, ribozyme- or mock-transfected as well
as untransfected 293 cells were assayed with the colorimetric
MTS test. As shown in Fig. 4, the number of cells upon treat-
ment with increasing amounts of serum was signi¢cantly low-
er compared to mock- or untransfected 293 cells, if anti-IEX-1
ribozymes were expressed. Ri2/8/9/10 exhibited the strongest
e¡ect: in the presence of 3% FCS for 48 h, the intensity of
MTS staining was reduced by almost 50%, and in cells treated
with lower amounts of FCS (1.5% or 0.5%), MTS staining
was decreased by 37% and 20%, respectively. Ri2/8/9 a¡ected
the growth rate of 293 cells at 3% and 1.5% FCS to a similar
extent (45% and 30% reduction, respectively) whereas Ri9 was
less e⁄cient (20% and 12% reduction, respectively).
In addition to the e¡ect on the cell cycle, the presence of
Fig. 1. Testing of in vitro transcribed hammerhead ribozymes on in vitro transcribed IEX-1 RNA or on total RNA from 293 cells. A: Upon
in vitro transcription, 12 di¡erent ribozymes (20 pmol) were used for cleavage (20 min, 37‡C) of 10 pmol in vitro transcribed IEX-1/exon 1
RNA (ribozymes 1^6; upper panel) or with IEX-1/exon 2 RNA (ribozymes 7^12; lower panel). The reaction (20 Wl total volume, 40 mM Tris^
HCl, pH 7.5) was started after 5 min pretreatment at 65‡C by addition of 1 Wl MgCl2 (500 mM) and terminated by addition of 2 Wl 300 mM
EDTA. B: Time-dependent cleavage of 10 pmol IEX-1/exon 2 RNA by 20 pmol of ribozyme 11 (conditions as described above). Products of
cleavage reactions were separated by PAGE and visualised by ethidium bromide staining. A representative result of three independent experi-
ments is shown. Sizes (bp) of cleavage products are indicated. C,D: In vitro transcribed ribozymes 2, 3, 5, 8, 9, 10, 11 and 12 (20 pmol) were
used for cleavage of (C) 10 pmol in vitro transcribed IEX-1 mRNA (position 1^568), or (D) 20 Wg total RNA from 293 cells containing native
IEX-1 mRNA (1.3 kb). Upon cleavage reaction (conditions as described above), products were analysed by (C) PAGE and silver staining (sizes
(bp) of cleavage products are indicated), or (D) Northern blotting. A representative result of three independent experiments is shown.
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Ri2/8/9/10 reduced the cytotoxic e¡ect of various apoptotic
triggers with the highest e⁄cacy. As shown in Fig. 5, the
increase of apoptotic 293 cells (basal, 7 þ 2%) in response to
an agonistic Fas antibody (CH-11) amounted to 400%, if
these cells were transfected with the empty vector (30 þ 4%
apoptotic cells). In contrast, Ri2/8/9/10 transfectants did not
exhibit this gain in apoptotic cell number (13 þ 3%) upon CH-
11 treatment. If induced by the anti-cancer drugs etoposide
(20 WM) and doxorubicin (0.5 WM), apoptosis in vector or
control transfectants amounted to 35 þ 6% and 43 þ 11, re-
spectively, whereas Ri2/8/9/10-transfected cells became signi¢-
cantly less apoptotic (11.3 þ 2% and 18 þ 7%, respectively). A
decrease of apoptosis was also noted in cells treated with the
proteasomal inhibitor MG132 that induced apoptosis in
25 þ 3% of mock- or untransfected cells, but only in 10 þ 2%
of cells expressing Ri2/8/9/10. In a similar fashion, Ri2/8/9,
and to a lesser extent Ri9, also diminished the apoptotic re-
sponse of 293 cells to the di¡erent stimuli.
4. Discussion
In the present study we elucidated to what extent disruption
of IEX-1 expression a¡ects cell growth and cell viability of
293 cells. In order to abolish IEX-1 expression, antisense ham-
merhead ribozymes were generated. Maximal e⁄cacy in cleav-
ing IEX-1 mRNA was achieved by generating a concatemer
of four di¡erent ribozymes joined to an intron sequence de-
Fig. 2. Ribozyme expression in stably transfected 293 cells. 293 cells were transduced with a retroviral expression vector (pBabePuro) encoding
the single ribozyme 9, the concatemeric ribozymes 2/8/9 and 2/8/9/10, or the empty vector (mock). A: The integration of ribozymal cDNA into
the genome of 293 cells was checked by PCR; arrows indicate speci¢c PCR products. B: RT-PCR analysis on total RNA samples pretreated
with DNase I was performed for the detection of ribozymal RNA; arrows indicate speci¢c PCR products. C,D: The e¡ect of ribozyme expres-
sion on IEX-1 expression was checked by (C) Northern blotting including an rRNA control and (D) Western blotting using K-tubulin as con-
trol. A representative result from three independent experiments is shown.
Fig. 3. Cell cycle characteristics in stably transfected 293 cells.
Transduced 293 cells (mock, and ribozymes 9, 2/8/9 or 2/8/9/10)
were serum-starved for 16 h, followed by stimulation with 5% FCS
for 24 h. Cell cycle analysis was performed using the PI staining
procedure. Data represent the mean þ S.D. of four independent ex-
periments.
Fig. 4. Growth properties of stably transfected 293 cells. 293 cells
were grown for 24^36 h, serum-starved for 12^26 h and stimulated
with increasing amounts of FCS (0.5%, 1.5% or 3%). Then, after an
additional 48 h, cell number was determined by the colorimetric
MTS test. Data represent the mean þ S.D. of four independent ex-
periments performed in quadruplicate.
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rived from the IEX-1 gene. Upon retroviral transfection,
mixed clones of 293 cells were established stably expressing
this concatemeric ribozyme RNA and exhibiting reduced ex-
pression of IEX-1 compared with mock transfectants. These
cells displayed a signi¢cant alteration in cell cycle progression
in that the fraction of cells residing in G2/M was lower com-
pared to mock-transfected cells, whereas the G1 fraction in-
creased. In accordance with this inhibition of cell cycle pro-
gression, the growth rate of 293 cells decreased if IEX-1
expression was abolished by the concatemeric ribozyme. In-
terestingly, the e⁄cacy in reducing IEX-1 expression (in the
rank order Ri96Ri2/8/96Ri2/8/9/10) was exactly paralleled
by the e⁄cacy in reducing the cell cycle progression as well as
the growth rate. Thus, disruption of IEX-1 expression obvi-
ously a¡ects signalling pathways during proliferation. These
¢ndings support earlier observations indicating a growth-pro-
moting activity of IEX-1 in certain epithelial cell lines [7] and
a close association of IEX-1 expression with growth-promot-
ing signals in vitro [1,4] as well as in vivo [3]. Furthermore, an
accelerating e¡ect of IEX-1 on cell cycle progression was ob-
served in HeLa cells [19]. During growth stimulation, IEX-1
protein enters the nucleus [12] and accumulates in distinct
subnuclear structures (H. Scha«fer, unpublished result) that
might be related to the so-called nuclear dots [20] or PML
oncogenic domains. Recent studies have revealed that these
particular nuclear structures are involved in growth regula-
tion, apoptosis and stress response [21^23]. Still, the exact
mechanisms by which IEX-1 exerts its cell cycle-promoting
e¡ect are unknown.
Another e¡ect caused by abolished IEX-1 expression was a
decrease of the sensitivity to apoptotic triggers, like Fas acti-
vation or anti-cancer drug treatment. This could be explained
by the fact that particularly those cells are prone to apoptosis
that proceeded in the cell cycle, whereas those cells residing in
G1 arrest are more refractory. A line of evidence supports this
link of apoptotic sensitivity and cell cycle (reviewed in [24^
26]). It has been demonstrated that the exaggerated activity of
c-myc and E2F accelerates cell cycle progression but also trig-
gers apoptosis induced by various apoptotic stimuli. As IEX-1
contributes to cell cycle progression, it might similarly in-
crease the sensitivity to apoptosis. Under conditions that fa-
vour cell growth, IEX-1 might be part of a growth signal, as
demonstrated by previous work. However, under unfavoura-
ble conditions, i.e. death receptor activation, IEX-1 facilitates
apoptosis. This may be due to a signal con£ict that emerges if
inappropriate cell cycle progression occurs [27], as already
described for other cell cycle-promoting mediators [28].
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Fig. 5. Fas- and anti-cancer drug-induced apoptosis in stably trans-
fected 293 cells. 293 cells were grown for 24^36 h. Then, cells were
treated with an agonistic anti-Fas antibody (clone CH-11, 150 ng/
ml) for 16 h, or with doxorubicin (0.5 WM), etoposide (20 WM) or
MG132 (50 ng/ml) for 24 h. Apoptosis was quanti¢ed by the
FITC^annexin V staining procedure (ApoAlert). Data represent the
mean þ S.D. of four independent experiments.
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